Clinical Trial Detail

NCT ID	NCT04136275
Title	CAR-37 T Cells In Hematologic Malignancies
Recruitment	Recruiting
Gender	both
Phase	Phase I
Variant Requirements	No
Sponsors	Marcela V. Maus, M.D.,Ph.D.
Indications	marginal zone B-cell lymphoma peripheral T-cell lymphoma cutaneous T cell lymphoma CLL/SLL chronic lymphocytic leukemia prolymphocytic leukemia diffuse large B-cell lymphoma follicular lymphoma mantle cell lymphoma
Therapies	Anti-CD37 CAR T cells
Age Groups:	senior adult